Zeremski V - Search Results

1

Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.

Richter S, Böttcher M, Stoll A, Zeremski V, Völkl S, Mackensen A, Ekici AB, Jacobs B, Mougiakakos D. Richter S, et al. Among authors: zeremski v. Transplant Cell Ther. 2024 Mar 7:S2666-6367(24)00257-4. doi: 10.1016/j.jtct.2024.03.005. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38460727 Free article.

2

Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.

Zeremski V, Adolph L, Beer S, Berisha M, Jacobs B, Kahl C, Koenecke C, Kropf S, Panse J, Petersen J, Schmidt-Hieber M, Schneider J, Vucinic V, Walter J, Weigert O, Witte HM, Mougiakakos D. Zeremski V, et al. Eur J Haematol. 2024 Apr;112(4):641-649. doi: 10.1111/ejh.14159. Epub 2024 Jan 2. Eur J Haematol. 2024. PMID: 38164819

3

Case report: Acute kidney injury as the initial manifestation of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Bender ST, Zeremski V, Wiech T, Mertens PR, Gross C. Bender ST, et al. Among authors: zeremski v. Front Med (Lausanne). 2023 Oct 20;10:1279005. doi: 10.3389/fmed.2023.1279005. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37928472 Free PMC article.

4

Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis.

Zeremski V, Kropf S, Koehler M, Gebauer N, McPhail ED, Habermann T, Schieppati F, Mougiakakos D. Zeremski V, et al. Front Oncol. 2023 Jul 20;13:1188478. doi: 10.3389/fonc.2023.1188478. eCollection 2023. Front Oncol. 2023. PMID: 37546419 Free PMC article.

5

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.

Treiber H, Nilius-Eliliwi V, Seifert N, Vangala D, Wang M, Seidel S, Mika T, Marschner D, Zeremski V, Wurm-Kuczera R, Caillé L, Chapuy CI, Trümper L, Fischer T, Altenbuchinger M, Wulf GG, Illerhaus G, Dietrich S, Schroers R, Chapuy B. Treiber H, et al. Among authors: zeremski v. Hemasphere. 2023 Jul 21;7(8):e926. doi: 10.1097/HS9.0000000000000926. eCollection 2023 Aug. Hemasphere. 2023. PMID: 37492436 Free PMC article.

6

CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.

Surov A, Meyer HJ, Hinnerichs M, Ferraro V, Zeremski V, Mougiakakos D, Saalfeld S, Wienke A, Strobel A, Wolleschak D. Surov A, et al. Among authors: zeremski v. Eur Radiol. 2024 Feb;34(2):790-796. doi: 10.1007/s00330-023-09712-y. Epub 2023 May 13. Eur Radiol. 2024. PMID: 37178198

7

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.

Zeremski V, McPhail ED, Habermann TM, Schieppati F, Gebauer N, Vassilakopoulos TP, Mougiakakos D. Zeremski V, et al. Hematol Oncol. 2023 Oct;41(4):776-780. doi: 10.1002/hon.3130. Epub 2023 Mar 21. Hematol Oncol. 2023. PMID: 36945194 No abstract available.

8

Prognostic Impact of Quality and Distribution of Adipose Tissue in Patients With Primary Central Nervous System Lymphoma.

Hinnerichs M, Ferraro V, Zeremski V, Mougiakakos D, Omari J, Pech M, Bär C, Wienke A, Saalfeld S, Strobel A, Surov A, Meyer HJ, Wolleschak D. Hinnerichs M, et al. Among authors: zeremski v. In Vivo. 2022 Nov-Dec;36(6):2828-2834. doi: 10.21873/invivo.13021. In Vivo. 2022. PMID: 36309379 Free PMC article.

9

Sarcopenia does not predict outcome in patients with CNS lymphoma undergoing systemic therapy.

Ferraro V, Thormann M, Hinnerichs M, Pech M, Wolleschak D, Mougiakakos D, Wienke A, Strobel A, Zeremski V, Surov A, Omari J. Ferraro V, et al. Among authors: zeremski v. Oncol Lett. 2022 Aug 22;24(4):355. doi: 10.3892/ol.2022.13475. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36168307 Free PMC article.

10

Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.

Momotow J, Bühnen I, Trautmann-Grill K, Kobbe G, Hahn D, Schroers R, Heinrich B, Gaska T, Forstbauer H, Schmidt B, Boger R, Hüttmann A, Heil G, Kraemer DM, Krüger W, Zeremski V, Grobe N, Jentsch-Ullrich K, Griesinger F, Fuchs M, von Tresckow B, Borchmann P, Engert A, Bröckelmann PJ. Momotow J, et al. Among authors: zeremski v. Br J Haematol. 2022 Jul;198(2):401-404. doi: 10.1111/bjh.18231. Epub 2022 May 11. Br J Haematol. 2022. PMID: 35538912 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page